Showing results (31-40 of 232) with videos related to
Sort By:
Pageof 24
World Journal of Diabetes|April 22, 2015
Gut microbiota and Ma-Pi 2 macrobiotic diet in the treatment of type 2 diabetesFrancesco Fallucca, Lucia Fontana, Sara Fallucca, et al.Diabetes/Metabolism Research and Reviews|February 18, 2014
Influence of diet on gut microbiota, inflammation and type 2 diabetes mellitus. First experience with macrobiotic Ma-Pi 2 dietFrancesco Fallucca, Carmen Porrata, Sara Fallucca, et al.Journal of Diabetes Investigation|May 21, 2014
One size does not fit all glycemic targets for type 2 diabetesPaolo Pozzilli, Rocky Strollo, Enzo BonoraNature Reviews. Endocrinology|February 18, 2015
Combination immunotherapies for type 1 diabetes mellitusPaolo Pozzilli, Ernesto Maddaloni, Raffaella BuzzettiDiabetes/Metabolism Research and Reviews|May 20, 2023
Diabetes, COVID-19, and questions unsolvedFelecia D'Souza, Raffaella Buzzetti, Paolo PozzilliDiabetes, Obesity & Metabolism|March 12, 2020
Impact of obesity on the increasing incidence of type 1 diabetesRaffaella Buzzetti, Simona Zampetti, Paolo PozzilliExpert Opinion on Biological Therapy|April 21, 2012
Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence?Andrea Palermo, Ernesto Maddaloni, Paolo PozzilliJournal of Diabetes and Its Complications|December 4, 2025
Corrigendum to 'What type 1 diabetes endotype is most suitable for anti-CD3 antibodies prevention trials?' [JDC, Vol. 39, Issue 10, October 2025, 109132]Maria Aurora Roma-Wilson, Paolo PozzilliDiabetes/Metabolism Research and Reviews|November 27, 2012
Epigenetics in autoimmune diseases with focus on type 1 diabetesMary Ngoc Dang, Raffaella Buzzetti, Paolo PozzilliDiabetes/Metabolism Research and Reviews|September 1, 2025
Metabolic Cardiovascular Renal Disease (Met-CVRD): A New NomenclaturePaolo Pozzilli, Maria Vittoria Messina, Michael RodenPageof 24